Literature DB >> 23416049

Formation of subnuclear foci is a unique spatial behavior of mating MAPKs during hyperosmotic stress.

Simon E Vidal1, David Pincus, Jacob Stewart-Ornstein, Hana El-Samad.   

Abstract

The assembly of signaling components and transcription factors in ordered subcellular structures is increasingly implicated as an important regulatory strategy for modulating the activity of cellular pathways. Here, we document the inducible formation of subnuclear foci formed by two mitogen-activated protein kinases (MAPKs) in Saccharomyces cerevisiae upon hyperosmotic stress. Specifically, we demonstrate that activation of the hyperosmotic stress response pathway induces the mating pathway MAPK Fus3 and the filamentation pathway MAPK Kss1 to form foci in the nucleus that are organized by their shared downstream transcription factor Ste12. Foci formation of colocalized Ste12, Fus3, and Kss1 requires the kinase activity of the hyperosmotic response MAPK Hog1 and correlates with attenuated signaling in the mating pathway. Conversely, activation of the mating pathway prevents foci formation upon subsequent hyperosmotic stress. These results suggest that Hog1-mediated spatial localization of Fus3 and Ste12 into subnuclear foci could contribute to uncoupling the pheromone and osmolarity pathways, which share signaling components, under high-osmolarity conditions.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23416049      PMCID: PMC3616637          DOI: 10.1016/j.celrep.2013.01.022

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  35 in total

Review 1.  The Cajal body and histone locus body.

Authors:  Zehra Nizami; Svetlana Deryusheva; Joseph G Gall
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-05-26       Impact factor: 10.005

2.  Hog1 mitogen-activated protein kinase (MAPK) interrupts signal transduction between the Kss1 MAPK and the Tec1 transcription factor to maintain pathway specificity.

Authors:  Teresa R Shock; James Thompson; John R Yates; Hiten D Madhani
Journal:  Eukaryot Cell       Date:  2009-02-13

3.  Dynamic localization of Fus3 mitogen-activated protein kinase is necessary to evoke appropriate responses and avoid cytotoxic effects.

Authors:  Raymond E Chen; Jesse C Patterson; Louise S Goupil; Jeremy Thorner
Journal:  Mol Cell Biol       Date:  2010-06-28       Impact factor: 4.272

4.  Single-cell analysis reveals that insulation maintains signaling specificity between two yeast MAPK pathways with common components.

Authors:  Jesse C Patterson; Evguenia S Klimenko; Jeremy Thorner
Journal:  Sci Signal       Date:  2010-10-19       Impact factor: 8.192

5.  A systems-level analysis of perfect adaptation in yeast osmoregulation.

Authors:  Dale Muzzey; Carlos A Gómez-Uribe; Jerome T Mettetal; Alexander van Oudenaarden
Journal:  Cell       Date:  2009-07-10       Impact factor: 41.582

6.  Dynamics and variability of ERK2 response to EGF in individual living cells.

Authors:  Cellina Cohen-Saidon; Ariel A Cohen; Alex Sigal; Yuvalal Liron; Uri Alon
Journal:  Mol Cell       Date:  2009-12-11       Impact factor: 17.970

7.  Coordinate control of gene expression noise and interchromosomal interactions in a MAP kinase pathway.

Authors:  Emma McCullagh; Anupama Seshan; Hana El-Samad; Hiten D Madhani
Journal:  Nat Cell Biol       Date:  2010-09-19       Impact factor: 28.824

Review 8.  Signal integration by JNK and p38 MAPK pathways in cancer development.

Authors:  Erwin F Wagner; Angel R Nebreda
Journal:  Nat Rev Cancer       Date:  2009-08       Impact factor: 60.716

Review 9.  Pathological roles of MAPK signaling pathways in human diseases.

Authors:  Eun Kyung Kim; Eui-Ju Choi
Journal:  Biochim Biophys Acta       Date:  2010-01-14

10.  The pheromone-induced nuclear accumulation of the Fus3 MAPK in yeast depends on its phosphorylation state and on Dig1 and Dig2.

Authors:  Ernest Blackwell; Hye-Jin N Kim; David E Stone
Journal:  BMC Cell Biol       Date:  2007-10-26       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.